We are live on ! Find out more
CL icon

Colgate-Palmolive

1,633 hedge funds and large institutions have $49.9B invested in Colgate-Palmolive in 2022 Q1 according to their latest regulatory filings, with 108 funds opening new positions, 577 increasing their positions, 615 reducing their positions, and 155 closing their positions.

New
Increased
Maintained
Reduced
Closed

34% more call options, than puts

Call options by funds: $330M | Put options by funds: $246M

0.29% more ownership

Funds ownership: 78.5%78.79% (+0.29%)

6% less repeat investments, than reductions

Existing positions increased: 577 | Existing positions reduced: 615

4% less funds holding

Funds holding: 1,7051,633 (-72)

11% less capital invested

Capital invested by funds: $55.9B → $49.9B (-$5.97B)

30% less first-time investments, than exits

New positions opened: 108 | Existing positions closed: 155

62% less funds holding in top 10

Funds holding in top 10: 135 (-8)

Holders
1,633
Holders Change
-72
Holders Change %
-4.22%
% of All Funds
25.75%
Holding in Top 10
5
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-61.54%
% of All Funds
0.08%
New
108
Increased
577
Reduced
615
Closed
155
Calls
$330M
Puts
$246M
Net Calls
+$83.8M
Net Calls Change
+$97.6M
Name Holding Trade Value Shares
Change
Change in
Stake
COPPSERS
301
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$8.55M +$553K +6,983 +7%
MOACM
302
Mutual of America Capital Management
New York
$8.54M +$92.9K +1,173 +1%
SLAM
303
Swiss Life Asset Management
$8.54M +$1.22M +15,371 +16%
LWCFA
304
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
$8.53M -$1.13M -14,288 -11%
DADC
305
D.A. Davidson & Co
Montana
$8.52M +$92.6K +1,169 +1%
VanEck Associates
306
VanEck Associates
New York
$8.52M -$343K -4,326 -4%
ATC
307
Argent Trust Co
Tennessee
$8.49M -$101K -1,281 -1%
TPSF
308
Texas Permanent School Fund
Texas
$8.29M -$549K -6,929 -6%
RFC
309
Regions Financial Corp
Alabama
$8.28M -$18.1K -228 -0.2%
GAM
310
Gotham Asset Management
New York
$8.21M +$930K +11,744 +12%
JIC
311
Johnson Investment Counsel
Ohio
$7.95M -$1.1M -13,848 -12%
X
312
Xponance
Pennsylvania
$7.88M +$157K +1,976 +2%
JIM
313
Jensen Investment Management
Oregon
$7.77M
PAM
314
Palisade Asset Management
Minnesota
$7.69M +$382K +4,821 +5%
RCYC
315
Richard C. Young & Co
Rhode Island
$7.66M -$261K -3,298 -3%
DILIC
316
Dai-ichi Life Insurance Company
Japan
$7.62M
VF
317
Vest Financial
Virginia
$7.55M +$757K +9,560 +11%
Tudor Investment Corp
318
Tudor Investment Corp
Connecticut
$7.49M +$7.82M +98,778 New
S
319
Seeyond
France
$7.45M +$2.1M +26,497 +37%
OSIA
320
O'Shares Investment Advisers
Massachusetts
$7.42M +$433K +5,464 +6%
RMA
321
Roffman Miller Associates
Pennsylvania
$7.37M -$13.2M -166,975 -63%
SC
322
Scotia Capital
Ontario, Canada
$7.36M +$126K +1,589 +2%
EGM
323
Engineers Gate Manager
New York
$7.26M +$6.55M +82,713 +632%
VIA
324
Vident Investment Advisory
Georgia
$7.2M +$57.7K +729 +0.8%
SAM
325
Shell Asset Management
Netherlands
$7.17M -$395K -4,983 -5%

CL Hedge Fund Activity: Q1 2022 in Review

1,633 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Colgate-Palmolive (CL) for Q1 2022, worth a combined $49.9B — down 11% from $55.9B a quarter earlier.

Sellers outnumbered buyers: 155 funds closed out of CL and 108 opened new positions — a net loss of 47 holders — while 615 trimmed existing stakes and 577 added.

The largest buyer was Renaissance Technologies, adding an estimated $271M. The largest seller was Loomis, Sayles & Company, cutting an estimated $713M.

  • 1,633 institutional investors held Colgate-Palmolive (CL) as of Q1 2022, down from 1,705 in Q4 2021.
  • Funds reported $49.9B of Colgate-Palmolive stock for Q1 2022, down 11% quarter-over-quarter.
  • 108 funds opened new Colgate-Palmolive positions in Q1 2022 and 155 closed out, a net change of -47 holders.
  • The largest Colgate-Palmolive buyer in Q1 2022 was Renaissance Technologies, an estimated $271M added.
  • The largest Colgate-Palmolive seller in Q1 2022 was Loomis, Sayles & Company, an estimated $713M sold.

Based on aggregated 13F filings for Q1 2022.